Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands... Show more
Emerson Electric is a global leader in automation technology and industrial software, delivering measurement instrumentation, control systems, valves, and software that help customers optimize operations across power generation, energy, semiconductor manufacturing, and life sciences. Its strategic pivot toward a higher-value, software-centric portfolio — anchored by the AspenTech industrial software business — has shifted the company's market positioning toward recurring revenue and structurally higher margins.
This transformation is central to Emerson's medium-term competitive outlook. Management has reported organic sales growth of roughly 7% on a five-year compounded basis, versus an industry average closer to 4%, while adjusted per-share earnings growth has meaningfully outpaced peers. The company's adjusted segment EBITA margin (earnings before interest, taxes, and amortization) is now running near 28%, supported by favorable mix, price-cost discipline, and cost reductions. Continued expansion of annual contract value, which surpassed $1.68 billion, reflects a deliberate shift toward sticky, software-driven revenue that can dampen cyclicality and support margin sustainability.
Several catalysts could shape investor sentiment over the coming quarters. The most immediate is Emerson's next earnings release, where investors will assess whether strong underlying order growth — up 7% in the most recent quarter — continues to convert into revenue and whether the company sustains its recently raised full-year guidance of approximately 5% sales growth and about $6.55 in adjusted earnings per share.
Capital allocation is another focal point. Emerson has signaled a pivot toward returning more cash to shareholders, with roughly $1 billion in planned share repurchases and about $1.2 billion in dividends for fiscal 2026, alongside a recently increased dividend. Strategic partnerships, such as a 13-year collaboration with energy producer Equinor spanning measurement instrumentation, analytical technologies, and lifecycle services, deepen Emerson's foothold in long-duration energy infrastructure.
Analyst activity has been notably active. Firms including Wells Fargo, Bernstein, and Evercore ISI have issued or reiterated Buy ratings with price targets ranging from roughly $177 to $190, while J.P. Morgan upgraded the stock to Buy. At the same time, Morgan Stanley and others have maintained more cautious stances, and firms such as TD Cowen and D.A. Davidson retain Hold-equivalent views. This mix reflects a consensus that is optimistic on long-cycle backlog conversion and power/LNG demand, but mindful of near-term tariff, currency, and regional-demand headwinds.
Emerson's trajectory is tightly linked to global investment in energy and industrial automation. Rising electricity demand driven by AI data centers, electrification, and grid modernization is fueling orders in Emerson's Ovation power-generation business, where orders rose roughly 31% year over year. Liquefied natural gas (LNG) investment and reshoring of semiconductor and manufacturing capacity provide additional structural tailwinds.
Macro conditions cut both ways. Higher-for-longer interest rates can pressure large project financing, while inflation and tariffs influence input costs and pricing. Foreign exchange volatility and softer demand in Europe and China have weighed on recent results, even as North America, the Middle East, and parts of Asia have shown strength. Geopolitical tensions in the Middle East represent both a near-term risk and a potential source of later repair-and-restart demand, as energy infrastructure is maintained and expanded.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, exchange-traded fund (ETF), or other asset may trend bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a broad range of tradable instruments. The platform includes searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. For investors tracking Emerson Electric, tools like this can complement fundamental analysis by adding a data-driven view of short- and medium-term price direction.
Looking ahead to 2026 and beyond, Emerson's long-term story centers on the convergence of automation, AI-driven industrial software, and rising global energy demand. The company's expanded project funnel and backlog suggest that long-cycle power, LNG, semiconductor, and aerospace and defense projects should contribute to a growth acceleration into 2027. Analysts have noted that improving rig counts and upward revisions to refinery capital spending forecasts could support a more favorable process-industry cycle.
Structural themes to watch include continued margin expansion from the software mix shift, sustained free cash flow generation (guided to roughly $3.6 billion for fiscal 2026), and disciplined capital allocation between buybacks, dividends, and strategic investments. Competitive threats from broader industrial automation peers and digital software rivals, along with the execution of the AspenTech integration, will be important factors in whether Emerson can preserve its premium positioning.
Consensus expectations remain generally positive, with an average analyst price target well above recent levels, but the range of targets is wide — reflecting genuine debate over the pace of backlog conversion, tariff impacts, and regional demand. As always, these figures represent external analyst estimates rather than a forecast from this article, and investors should weigh them against the company's execution and the evolving macro backdrop.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a developer of process controls systems, valves and analytical instruments
Industry IndustrialMachinery
A.I.dvisor indicates that over the last year, EMR has been closely correlated with AME. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if EMR jumps, then AME could also see price increases.
| Ticker / NAME | Correlation To EMR | 1D Price Change % |
|---|---|---|
| EMR | 100% | +0.45% |
| EMR (5 stocks) | 82% Closely correlated | +0.82% |
| Producer Manufacturing (350 stocks) | 14% Poorly correlated | -0.40% |
EMR saw its Momentum Indicator move above the 0 level on September 22, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In 61 of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at 66%.
The Moving Average Convergence Divergence (MACD) for EMR just turned positive on September 22, 2026. Looking at past instances where EMR's MACD turned positive, the stock continued to rise in 27 of 45 cases over the following month. The odds of a continued upward trend are 60%.
EMR moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for EMR crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +2.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 211 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
EMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
The Aroon Indicator for EMR entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 25 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.363) is normal, around the industry mean (5.342). P/E Ratio (34.877) is within average values for comparable stocks, (66.065). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.014) settles around the average of (0.014) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (186.943).
The Tickeron SMR rating for this company is 61 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.